According to
TAIPED, the Mentekidis construction company is active in the property market
in northern Greece, and the utilization of the above property, which covers
253,000 square meters, will require the investment of some 50 million euros,
which will contribute to the upgrading of tourism in the broader region and
create a considerable number of jobs.
Eurobank: According
to internet articles Eurobank’s data room will open for interested
strategic investors by the end of the month. Interested parties include:
Fairfax, a consortium between Eaglevale –Rothchild & Third Point
and Apollo
Autohellas: As of
today the shares of the company are traded on the ATHEX with new par value of
€ 0.32 per share, and excluding the right to participate in the capital
return of € 0.64 per share - through a cash payment - to the
shareholders of the company.
NBG: Finansbank
reported its 3Q13 bank-only net earnings as TRY124mn, indicating both a 46%
q/q and y/y decline. The sharp decline at the bottom line on a quarterly
basis is attributable to lower net interest income and higher trading losses
registered from the derivative transactions. Finansbank’s loan book
grew by 5% q/q in 3Q13. Deposits remained flat q/q, while its FX deposits
grew by 9% q/q in USD terms. At the end of 9M13, its loan/deposit ratio was
110%, while its TRY loans/deposits was 145% as the bank utilized more
alternative funding tools to increase its TRY loans. FX loans/FX deposits
stood at 36% and the bank used its FX liquidity to create TRY liquidity
by using cross-currency swaps. Quarterly NIM declined by 60bp q/q to 6.3%,
while its 9M13 NIM stood at 6.74%. Accordingly, Finansbank’s net
interest income declined by 4% q/q in 3Q13, while the bank registered 18% y/y
growth in y-t-d terms. Finansbank’s total capital adequacy ratio was
17.7% at the end of 9M13, well above the regulatory limit of 12%. The bank
posted a quarterly ROE of 6.6%, down from 12% a quarter ago. As of 9M13,
Finansbank’s ROE was 11.3%.
OPAP (Results 9M
2013 – Conference Call Highlights): Following the announcement of 3Q13
results OPAP’s new management team held a conference call. Main points
are the following:
¡
Management maintained FY 2013 EBITDA
guidance for EUR 243m
¡
Lottery & scratch cards will be
delayed and will commence operations at the end of 1Q14
¡
Management commented that they intend to
have a productive cooperation with their partners in Hellenic Lotteries
namely Intralot and SG; however they intend to renegotiate contract terms
with Intralot and SG since some parts of the contract are not beneficial for
Hellenic Lotteries (clearly referring to the 3.3% fee for the supply
agreement with Intralot and SG)
¡
Previous management expected that lottery
& scratch cards will contribute c. EUR 10m at EBITDA line for 2013.
Despite the delays in the commencement of operations for the lottery &
scratch cards the management maintained previous guidance; the EUR 10m will
be generated from revenue growth initiatives and mainly the robust
performance of Stihima that continues during 4Q13 supported by a relative
improved economic environment
¡
VLTs: First machines will be deployed
during 3Q14 while the first machines of the subcontractors should be expected
early in 2015
¡
Management stated that they have a good
relationship with the Greek Gaming Committee but they cannot further comment
on the issue of the temporary licenses
On the negative side
we point out the delays in the commencement of operations of the lottery
& scratch cards (end of 1Q14). On the positive side we notice the robust
performance of the land based games during H213 that will fully offset the
loss of EUR 10m at EBITDA level due to the delays with the lottery &
scratch cards. Negotiations with Intralot and SG may be proved beneficial for
OPAP since they will lead to reduced costs of the supply agreements with the
two providers assuming that they will result in further delays in the lottery
& scratch cards. Investors will still be looking on the timeframe of the
deployment of the VLT’s since they will generate c. 45% of
Group’s GGRs for 2015.
OPAP
|
Results
9M 2013
|
In
thous. euro
|
2012
|
2013
|
Δ
|
Sales
|
2,946,100
|
2,641,831
|
-10.3%
|
Q3
|
891,285
|
897,557
|
0.7%
|
EBITDA
|
499,601
|
174,098
|
-65.2%
|
(% Sales)
|
16.96%
|
6.59%
|
-1,037
bps
|
Q3
|
155,016
|
70,802
|
-54.3%
|
(% Sales)
|
17.39%
|
7.89%
|
-950
bps
|
Net
Income
|
371,675
|
111,701
|
-69.9%
|
(% Sales)
|
12.62%
|
4.23%
|
-839
bps
|
Q3
|
113,629
|
44,388
|
-60.9%
|
(% Sales)
|
12.75%
|
4.95%
|
-780
bps
|
ELVAL (Results 9M
2013): Sales
volume for the 9M period rose by 3% to 252,000 tons. The turnover fell by
2.9% to 778.9 million euro, being affected by the low aluminium market
prices. Gross profit registered a marginal drop and amounted to 66.6 million
euro compared to 6.8 million euro in the respective last year nine month
period. EBITDA amounted to 67.8 million euro, increased by 3.3%, and
consolidated earnings before taxes rose to 22.2 million euro compared to
21.0 million euro in 2012. Net results after taxes and non-controlling
interest stood at profits of 2.0 million euro compared to profits of 17.5
million euro in the respective last year nine month period due to the
increased taxes which arose from the recalculation of the deferred tax
liability that was the consequence of an increase in the tax rate from 20% to
26% and was fully charged to the results of the nine month period on a
lump-sum basis.
The earnings before
taxes and depreciation of the period, the low LME price and the management of
working capital resulted in positive operating cash flow maintained and
amounting to 43.2 million euro. The investment expenditures made in equipment
amounted to 48 million euro and primarily concern the investment plans that
continued to be implemented in the plants of Oinofyta and Great Britain. The
Group’s total cash outflows amounted to 8.4 million euro and net
borrowing amounted to 213.7 million euro.
Other Q3 Results:
Thrace Plastics
|
Results
9M 2013
|
In
thous. euro
|
2012
|
2013
|
Δ
|
Sales
|
206,677
|
204,465
|
-1.1%
|
Q3
|
69,451
|
70,828
|
2.0%
|
EBITDA
|
21,096
|
16,557
|
-21.5%
|
(% Sales)
|
10.21%
|
8.10%
|
-211
bps
|
Q3
|
6,437
|
5,862
|
-8.9%
|
(% Sales)
|
9.27%
|
8.28%
|
-99
bps
|
Net
Income
|
7,279
|
4,273
|
-41.3%
|
(% Sales)
|
3.52%
|
2.09%
|
-143
bps
|
Q3
|
2,582
|
1,457
|
-43.6%
|
(% Sales)
|
3.72%
|
2.06%
|
-166
bps
|
Info - Quest
|
Results
9M 2013
|
In
thous. euro
|
2012
|
2013
|
Δ
|
Sales
|
202,764
|
209,685
|
3.4%
|
Q3
|
67,434
|
68,743
|
1.9%
|
EBITDA
|
7,188
|
8,754
|
21.8%
|
(% Sales)
|
3.55%
|
4.17%
|
+63
bps
|
Q3
|
3,090
|
3,029
|
-2.0%
|
(% Sales)
|
4.58%
|
4.41%
|
-18
bps
|
Net
Income
|
-1,917
|
482
|
125.1%
|
(% Sales)
|
-0.95%
|
0.23%
|
+118
bps
|
Q3
|
-1,497
|
368
|
124.6%
|
(% Sales)
|
-2.22%
|
0.54%
|
+276
bps
|
Kyriakides
|
Results
9M 2013
|
In
thous. euro
|
2012
|
2013
|
Δ
|
Sales
|
26,550
|
28,131
|
6.0%
|
Q3
|
10,285
|
10,717
|
4.2%
|
EBITDA
|
7,705
|
10,815
|
40.4%
|
(% Sales)
|
29.02%
|
38.45%
|
+942
bps
|
Q3
|
2,199
|
4,235
|
92.6%
|
(% Sales)
|
21.38%
|
39.52%
|
+1,814
bps
|
Net
Income
|
3,204
|
4,910
|
53.2%
|
(% Sales)
|
12.07%
|
17.45%
|
+539
bps
|
Q3
|
905
|
2,801
|
209.5%
|
(% Sales)
|
8.80%
|
26.14%
|
+1,734
bps
|
Flexopack
|
Results 9M 2013
|
In thous. euro
|
2012
|
2013
|
Δ
|
Sales
|
40,721
|
41,139
|
1.0%
|
Q3
|
14,079
|
13,779
|
-2.1%
|
EBITDA
|
5,675
|
5,787
|
2.0%
|
(% Sales)
|
13.94%
|
14.07%
|
+13
bps
|
Q3
|
2,124
|
1,847
|
-13.0%
|
(% Sales)
|
15.09%
|
13.40%
|
-168 bps
|
Net Income
|
2,730
|
1,868
|
-31.6%
|
(%
Sales)
|
6.70%
|
4.54%
|
-216
bps
|
Q3
|
1,103
|
800
|
-27.5%
|
(% Sales)
|
7.83%
|
5.81%
|
-203 bps
|
|
0 σχόλια:
Δημοσίευση σχολίου
Ο σχολιασμός επιτρέπεται μόνο σε εγγεγραμμένους χρήστες